Aberrant cytokine signaling in leukemia

被引:81
作者
Van Etten, R. A. [1 ]
机构
[1] Tufts Univ New England Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA
[2] Tufts Univ New England Med Ctr, Div Hematol Oncol, Boston, MA 02111 USA
关键词
tyrosine kinase; kinase inhibitor; leukemia stem cell;
D O I
10.1038/sj.onc.1210758
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Abnormalities of cytokine and growth factor signaling pathways are characteristic of all forms of leukemia: lymphoid and myeloid, acute and chronic. In normal hematopoietic cells, cytokines provide the stimulus for proliferation, survival, self- renewal, differentiation and functional activation. In leukemic cells, these pathways are usurped to subserve critical parts of the malignant program. In this review, our current knowledge of leukemic cell cytokine signaling will be summarized, and some speculations on the significance and implications of these insights will be advanced. A better understanding of aberrant cytokine signaling in leukemia should provide additional targets for the rational therapy of these diseases.
引用
收藏
页码:6738 / 6749
页数:12
相关论文
共 139 条
[1]   HOXB4-induced expansion of adult hematopoietic stem cells ex vivo [J].
Antonchuk, J ;
Sauvageau, G ;
Humphries, RK .
CELL, 2002, 109 (01) :39-45
[2]   Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta [J].
Apperley, JF ;
Gardembas, M ;
Melo, JV ;
Russell-Jones, R ;
Bain, BJ ;
Baxter, J ;
Chase, A ;
Chessells, JM ;
Colombat, M ;
Dearden, CE ;
Dimitrijevic, S ;
Mahon, FX ;
Marin, D ;
Nikolova, Z ;
Olavarria, E ;
Silberman, S ;
Schultheis, B ;
Cross, NCP ;
Goldman, JM .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :481-487
[3]   Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation [J].
Araki, T ;
Mohi, MG ;
Ismat, FA ;
Bronson, RT ;
Williams, IR ;
Kutok, JL ;
Yang, WT ;
Pao, LI ;
Gilliland, DG ;
Epstein, JA ;
Neel, BG .
NATURE MEDICINE, 2004, 10 (08) :849-857
[4]   The t(4;22)(q12;q11) in atypical chronic myeloid leukaemia fuses BCR to PDGFRA [J].
Baxter, EJ ;
Hochhaus, A ;
Bolufer, P ;
Reiter, A ;
Fernandez, JM ;
Senent, L ;
Cervera, J ;
Moscardo, F ;
Sanz, MA ;
Cross, NCP .
HUMAN MOLECULAR GENETICS, 2002, 11 (12) :1391-1397
[5]   Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].
Baxter, EJ ;
Scott, LM ;
Campbell, PJ ;
East, C ;
Fourouclas, N ;
Swanton, S ;
Vassiliou, GS ;
Bench, AJ ;
Boyd, EM ;
Curtin, N ;
Scott, MA ;
Erber, WN ;
Green, AR .
LANCET, 2005, 365 (9464) :1054-1061
[6]   Constitutive activity of signal transducer and activator of transcription 3 protein in acute myeloid leukemia blasts is associated with short disease-free survival [J].
Benekli, M ;
Xia, Z ;
Donohue, KA ;
Ford, LA ;
Pixley, LA ;
Baer, MR ;
Baumann, H ;
Wetzler, M .
BLOOD, 2002, 99 (01) :252-257
[7]   Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation [J].
Bhardwaj, G ;
Murdoch, B ;
Wu, D ;
Baker, DP ;
Williams, KP ;
Chadwick, K ;
Ling, LE ;
Karanu, FN ;
Bhatia, M .
NATURE IMMUNOLOGY, 2001, 2 (02) :172-180
[8]   Somatic activation of oncogenic Kras in hematopoietic cells initiates a rapidly fatal myeloproliferative disorder [J].
Braun, BS ;
Tuveson, DA ;
Kong, N ;
Le, DT ;
Kogan, SC ;
Rozmus, J ;
Le Beau, MM ;
Jacks, TE ;
Shannon, KM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (02) :597-602
[9]   Reduced lymphomyeloid repopulating activity from adult bone marrow and fetal liver of mice lacking expression of STAT5 [J].
Bunting, KD ;
Bradley, HL ;
Hawley, TS ;
Moriggl, R ;
Sorrentino, BP ;
Ihle, JN .
BLOOD, 2002, 99 (02) :479-487
[10]   Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr/Abl [J].
Carlesso, N ;
Frank, DA ;
Griffin, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (03) :811-820